Should I Buy HTFL? HTFL 2026 Analysis

Should You Buy Heartflow Inc (HTFL) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

27.740

1 Day change

6.73%

52 Week Range

41.220

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Intellectia Proprietary Trading Signals\n - AI Stock Picker: No signal on given stock today.\n - SwingMax: No signal on given stock today.\n- Buy now for a tactical rebound setup: HTFL is extremely oversold (RSI_6 ~~17) and sitting right on/just below a key support zone (~~28.05), which often attracts dip-buying.\n- Street + options skew remain strongly bullish (multiple Buy/Overweight ratings with $38–$40 targets; very low put/call ratios), supporting a near-term bounce thesis.\n- Key trade expectation: rebound attempts are more likely than immediate upside continuation, so this is a “buy-the-dip” entry rather than a confirmed uptrend buy.

Technical Analysis

Trend/Momentum: Bearish momentum still present; MACD histogram is negative (-0.683) and expanding, suggesting the down-move hasn’t fully cooled yet.\n- Overbought/Oversold: RSI_6 at ~17 = deeply oversold, often consistent with short-term mean reversion bounces.\n- Moving averages: Converging MAs suggests a transition zone, but not a confirmed reversal yet.\n- Levels to watch: Pivot 31.31 (reclaiming this improves the chart); immediate support S1 28.052 (current price ~27.97 is slightly below); next support S2 26.039; resistance R1 34.569 then R2 36.582.\n- Near-term pattern read (provided): similar-pattern stats imply modest upside bias near-term (next day +1.23% probability profile; next month +3.5% expectation).

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

\n- Sentiment: Extremely call-skewed positioning (OI put/call 0.16; volume put/call 0.01) = strong bullish/speculative tone.\n- Activity spike: Today’s option volume is far above average (today vs 30-day avg ~1646.77%), indicating elevated attention/positioning.\n- Volatility: 30D IV ~97.59 vs historical vol ~57.33 and IV percentile ~88.46 = options are pricing large moves (market expecting sizable near-term swing).

Technical Summary

Sell

Buy

Positive Catalysts

reinforces investor confidence narrative.\n- Category leadership: Analysts emphasize first-mover advantage in AI/software for coronary artery disease (FFRCT and plaque analyses).\n- Upcoming event: QDEC 2025 earnings on 2026-02-18 (after hours) can act as a catalyst if results/guidance confirm the growth trajectory.\n- Business momentum (latest reported quarter): 2025/Q3 revenue growth was strong (+40.51% YoY) with high gross margin (~76.53%).

Neutral/Negative Catalysts

increases the chance of a test toward S2 (~26.
before a durable bounce.\n- News flow relevance: The provided news is largely about Aclarion, with HeartFlow mentioned only as a comparison—no direct fresh company-specific positive catalyst in the headline set.

Financial Performance

Latest quarter (2025/Q3): Revenue $46.276M, +40.51% YoY (strong top-line growth).\n- Profitability: Gross margin ~76.53% (very strong for a software/AI-like model).\n- Bottom line trend: Net income -50.855M and EPS -1.04 (loss-making; the YoY change metrics provided indicate losses did not meaningfully improve).\n- Takeaway: Excellent growth + high margins, but the investment case still hinges on operating leverage improving over time.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Ratings have been consistently bullish since the IPO period, with multiple firms reiterating Buy/Overweight and raising price targets.\n- Key updates:\n - 2026-01-28 Wells Fargo initiated Overweight, PT $38 (expects ~20% growth next 3 years; first-mover advantage).\n - 2025-11-13 Canaccord Buy, PT raised to $40.\n - 2025-11-13 JPMorgan Overweight, PT raised to $40.\n - 2025-11-13 Stifel Buy, PT raised to $40.\n- Wall St pros: clear leadership narrative, strong growth, high gross margins.\n- Wall St cons: still loss-making; near-term expectations/guidance conservatism can create volatility around earnings.

5 Analyst Rating

Wall Street analysts forecast HTFL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HTFL is 38.6 USD with a low forecast of 35 USD and a high forecast of 40 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

1 Hold

0 Sell

Strong Buy

Current: 25.990

Low

Averages

38.6

High

Current: 25.990

Low

Averages

38.6

High

Wells Fargo

NULL -> Overweight

initiated

$38

AI Analysis

2026-01-28

Reason

Wells Fargo

Price Target

$38

AI Analysis

2026-01-28

initiated

NULL -> Overweight

Reason

Wells Fargo initiated coverage of Heartflow with an Overweight rating and $38 price target. The firm sees upside to Street estimates from he company's fractional flow reserve-computed tomography and plaque volumes. Heartflow has a "strong first mover advantage" in software and AI-based diagnosis and management of coronary artery disease, a leading cause of death, the analyst tells investors in a research note. Wells sees the company as a 20% grower the next three years driven by its FFRCT and plaque analyses.

Canaccord

Buy

maintain

$39 -> $40

2025-11-13

Reason

Canaccord

Price Target

$39 -> $40

2025-11-13

maintain

Buy

Reason

Canaccord raised the firm's price target on Heartflow to $40 from $39 and keeps a Buy rating on the shares. The firm said HeartFlow delivered a strong Q3/25 beat fresh out of the IPO gate and formally issued guidance ahead of estimates, but very conservative.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HTFL

Unlock Now

HTFL Should I Buy

HTFL Should I Buy

Should You Buy Heartflow Inc (HTFL) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch